(1.12%) 5 066.69 points
(0.58%) 38 461 points
(1.54%) 15 689 points
(1.14%) $82.83
(-0.34%) $1.785
(-0.60%) $2 332.30
(0.12%) $27.28
(-0.91%) $922.85
(-0.40%) $0.935
(-0.49%) $10.93
(-0.72%) $0.804
(-0.17%) $93.25
Live Chart Being Loaded With Signals
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery...
Stats | |
---|---|
Today's Volume | 18 575.00 |
Average Volume | 494 900 |
Market Cap | 27.60M |
EPS | $0 ( 2024-04-12 ) |
Next earnings date | ( $-0.130 ) 2024-07-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.65 |
ATR14 | $0.0190 (0.85%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Cabatuan Nelson | Sell | 200 000 | Stock Options |
2023-10-26 | Carle Vanessa | Buy | 12 500 | Stock Options |
2023-10-26 | Docherty John Martin | Buy | 30 000 | Stock Options |
2023-10-26 | Bunka Christopher | Buy | 30 000 | Stock Options |
2023-07-25 | Baxter Nicholas W | Buy | 5 000 | Stock Options |
INSIDER POWER |
---|
-24.44 |
Last 99 transactions |
Buy: 4 974 810 | Sell: 2 651 735 |
Volume Correlation
Lexaria Bioscience Corp. Correlation
10 Most Positive Correlations | |
---|---|
RMRM | 0.854 |
AKU | 0.828 |
GAINL | 0.828 |
LPLA | 0.824 |
UNB | 0.822 |
LMST | 0.821 |
OCFC | 0.809 |
SFBC | 0.807 |
EFSC | 0.807 |
LBAI | 0.806 |
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lexaria Bioscience Corp. Correlation - Currency/Commodity
Lexaria Bioscience Corp. Financials
Annual | 2023 |
Revenue: | $226 208 |
Gross Profit: | $194 708 (86.07 %) |
EPS: | $-1.010 |
Q4 | 2023 |
Revenue: | $-3 433.00 |
Gross Profit: | $-6 866.00 (200.00 %) |
EPS: | $-0.190 |
Q3 | 2023 |
Revenue: | $93 150.00 |
Gross Profit: | $80 403.00 (86.32 %) |
EPS: | $-0.370 |
Q2 | 2023 |
Revenue: | $35 015.00 |
Gross Profit: | $32 057.00 (91.55 %) |
EPS: | $-0.220 |
Financial Reports:
No articles found.
Lexaria Bioscience Corp.
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and others. DehydraTECH also deliver drugs effectively across the blood brain barrier. It operates a licensed in-house research laboratory and holds intellectual property portfolio with 23 patents granted and approximately 50 patents pending worldwide. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators